Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Diwei Huayu Bio-Technology is a high-tech enterprise based in Beijing, China, dedicated to the field of molecular in vitro diagnostics (IVD). The company integrates research and development, production, and sales of diagnostic reagents and automated instruments. Its core product line focuses on Human Papillomavirus (HPV) genotyping, respiratory pathogen detection, and nucleic acid extraction technologies. Diwei Huayu's solutions are widely utilized in clinical settings for cervical cancer screening and infectious disease management. The company maintains a GMP-compliant manufacturing facility to support its growing portfolio of NMPA-approved diagnostic kits.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Diwei Huayu Bio-Technology.